Pfizer

ELELYSO

Manufacturer:

Pfizer

Elelyso HCPCS:

J3060

HCPCS Code Descriptor:

Injection, taliglucerase alfa, 10 units

Category:

J Code

Elelyso NDCs:

00069-0106-01

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Elelyso:

ELELYSO is an Enzyme Replacement Therapy drug manufactured by Pfizer and administered via the Intravenous route of administration. The J Code: J3060 is aligned to the drug ELELYSO.

ACCESS PRICING AND MORE BY REGISTERING

J3060 Added Date:

January 1, 2014

J3060 Effective Date:

January 1, 2014

J3060 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Elelyso billing and coding information.
Elelyso patient assistance information can be found through Pfizer Rx Pathways at the URL: https://www.pfizerrxpathways.com/
ELELYSO prescribing information can be found at the link below:
Information regarding ELELYSO’s side effects can be found at MedlinePlus